HER-2/neu expression in germ cell tumours

Journal of Clinical Pathology

Volumn 55, Issue 9, 2002, Pages 656-658

  Soule, S ^a   Miller, K ^a   Baldridge, L ^a   Kirkpatrick, K ^a   Cheng, L ^a   Gilbert, J L ^a   Smith, L R ^a   Thurston, V C ^a   Vance, G H ^a   Einhorn, L ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRASTUZUMAB;

ARTICLE; CENTROMERE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE OVEREXPRESSION; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS;

GENE EXPRESSION; GENES, ERBB-2; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHATIC METASTASIS; MALE; MEDIASTINAL NEOPLASMS; NEOPLASMS, GERM CELL AND EMBRYONAL; RECEPTOR, ERBB-2; RETROPERITONEAL SPACE; TESTICULAR NEOPLASMS;

EID: 0036724737     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.55.9.656     Document Type: Article

References (18)

1. Treatment of testicular cancer: A new and improved model
2. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
3. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
4. Superior outcomes with herceptin (trastuzumab) (H) in fluorescence in situ hybridization (FISH)-selected patients
5. HER-2/neu screening in advanced non-small cell lung cancer (NSCLC): A California cancer consortium trial of trastuzumab and docetaxel
6. HER-2/neu screening in hormone refractory prostate cancer (HRPC): A California cancer consortium trial of trastuzumab and docetaxel
7. HER-2 expression in androgen-independent prostate cancer
8. Analysis of HER-2/neu overexpression in primary and metastatic transitional cell carcinoma of the bladder
9. HER-2/neu receptor protein over-expression in grade I, II and III bladder transitional cell carcinoma
10. HER-2/neu overexpression in pancreatic adenocarcinoma
11. Herceptin and Gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu
12. HER-2/neu overexpression in adenocarcinoma of the distal esophagus
13. Prognostic factors in osteosarcoma - Role of HER-2/neu and p53: An immunohistochemical (IHC) and fluorescence in situ hybridization (FISH) analysis
14. HER-2/neu protein overexpression is a rare event in adult soft tissue sarcomas
15. C-ERB-2 (HER-2/neu) overexpression in recurrent germ cell tumors
16. Recommendations for HER2 testing in the UK
17. Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER-2 immunophenotype and gene amplification
18. Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: Apparent immunohistochemical false-positives do not get the message